A Better Life For Patients With Rare Diseases

ACERAGEN

Our Vision

Aceragen is a rare disease biopharmaceutical company. We take on rare, orphan diseases that typically have no approved treatments, and to develop important therapies to help patients. The needs of patients who suffer from under-served rare diseases drive our mission.

Learn More

Patient Info

The needs of patients who suffer from unserved or under-served rare diseases drive our mission at Aceragen

Learn More

Latest News

Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic Outlook

Company completes preferred stock conversion, implements reverse stock split, and regains Nasdaq compliance Company positioned for success with late-stage rare disease portfolio and multiple clinical milestones in 2023 DURHAM, N.C....

  • January, 2023
  • | by Aceragen
Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

EXTON, Pa. and DURHAM, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its consolidated financial and operational...

  • November, 2022
  • | by Aceragen